Enabling Adoption of 2d-NMR for the Higher Order Structure Assessment of Monoclonal Antibody Therapeutics

mAbs - United States
doi 10.1080/19420862.2018.1544454
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy